| Angiotensin–neprilysin inhibition versus enalapril in heart failure JJV McMurray, M Packer, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ... New England Journal of Medicine 371 (11), 993-1004, 2014 | 6777 | 2014 |
| Cardiac resynchronization in chronic heart failure WT Abraham, WG Fisher, AL Smith, DB Delurgio, AR Leon, E Loh, ... New England Journal of Medicine 346 (24), 1845-1853, 2002 | 6455 | 2002 |
| Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction B Pitt, W Remme, F Zannad, J Neaton, F Martinez, B Roniker, R Bittman, ... New England Journal of Medicine 348 (14), 1309-1321, 2003 | 6194 | 2003 |
| Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both MA Pfeffer, JJV McMurray, EJ Velazquez, JL Rouleau, L Køber, ... New England Journal of Medicine 349 (20), 1893-1906, 2003 | 3324 | 2003 |
| Spironolactone for heart failure with preserved ejection fraction B Pitt, MA Pfeffer, SF Assmann, R Boineau, IS Anand, B Claggett, ... New England Journal of Medicine 370 (15), 1383-1392, 2014 | 2606 | 2014 |
| Combination of isosorbide dinitrate and hydralazine in blacks with heart failure AL Taylor, S Ziesche, C Yancy, P Carson, R D'Agostino Jr, K Ferdinand, ... New England Journal of Medicine 351 (20), 2049-2057, 2004 | 2089 | 2004 |
| Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction SD Solomon, JJV McMurray, IS Anand, J Ge, CSP Lam, AP Maggioni, ... New England Journal of Medicine 381 (17), 1609-1620, 2019 | 1820 | 2019 |
| Angiotensin–neprilysin inhibition in acute decompensated heart failure EJ Velazquez, DA Morrow, AD DeVore, CI Duffy, AP Ambrosy, ... New England Journal of Medicine 380 (6), 539-548, 2019 | 1172 | 2019 |
| Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial M Gheorghiade, WA Gattis, CM O'Connor, KF Adams Jr, U Elkayam, ... Jama 291 (16), 1963-1971, 2004 | 767 | 2004 |
| Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of … WA Gattis, CM O'Connor, DS Gallup, V Hasselblad, M Gheorghiade, ... Journal of the American College of Cardiology 43 (9), 1534-1541, 2004 | 392 | 2004 |
| Triglyceride lowering with pemafibrate to reduce cardiovascular risk A Das Pradhan, RJ Glynn, JC Fruchart, JG MacFadyen, ES Zaharris, ... New England Journal of Medicine 387 (21), 1923-1934, 2022 | 328 | 2022 |
| Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure SH Lecker, A Zavin, P Cao, R Arena, K Allsup, KM Daniels, J Joseph, ... Circulation: Heart Failure 5 (6), 812-818, 2012 | 287 | 2012 |
| Aliskiren, enalapril, or aliskiren and enalapril in heart failure JJV McMurray, H Krum, WT Abraham, K Dickstein, LV Køber, AS Desai, ... New England Journal of Medicine 374 (16), 1521-1532, 2016 | 250 | 2016 |
| Transforming growth factor β receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II K Chen, JL Mehta, D Li, L Joseph, J Joseph Circulation research 95 (12), 1167-1173, 2004 | 227 | 2004 |
| Effects of serelaxin in patients with acute heart failure M Metra, JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ... New England Journal of Medicine 381 (8), 716-726, 2019 | 219 | 2019 |
| Inhibition of LOX-1 by statins may relate to upregulation of eNOS JL Mehta, DY Li, HJ Chen, J Joseph, F Romeo Biochemical and biophysical research communications 289 (4), 857-861, 2001 | 178 | 2001 |
| Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats J Joseph, L Joseph, NS Shekhawat, S Devi, J Wang, RB Melchert, ... American Journal of Physiology-Heart and Circulatory Physiology 285 (2 …, 2003 | 174 | 2003 |
| Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced … J Shi, J Wang, H Zheng, W Ling, J Joseph, D Li, JL Mehta, U Ponnappan, ... Blood coagulation & fibrinolysis 14 (6), 575-585, 2003 | 159 | 2003 |
| Prescription fill patterns for commonly used drugs during the COVID-19 pandemic in the United States M Vaduganathan, J van Meijgaard, MR Mehra, J Joseph, CJ O’Donnell, ... Jama 323 (24), 2524-2526, 2020 | 155 | 2020 |
| Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19 L Gaziano, C Giambartolomei, AC Pereira, A Gaulton, DC Posner, ... Nature medicine 27 (4), 668-676, 2021 | 137 | 2021 |
